癌症中的髓原抑制细胞:当前的知识和未来的前景
Sunanda Rajkumari1, Jaspreet Singh2, Usha Agrawal3
1ICMR National Institute of Medical Statistics, Ansari Nagar, New Delhi 110029, India.
International immunopharmacology
|September 5, 2024
概括
骨髓系衍生抑制细胞 (MDSCs) 促进癌症的免疫逃避和不良预后. 针对MDSC提供了一个有希望的策略,以改善癌症治疗结果和免疫监测.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 骨髓系衍生抑制细胞 (MDSCs) 是癌症免疫规避的关键参与者.
- MDSCs在瘤和血液中积累,抑制T细胞和NK细胞等抗癌免疫细胞.
- 它们促进瘤生长,血管新生和转移,创造了一个支持瘤的环境.
研究的目的:
- 提供关于癌症中髓质衍生抑制细胞 (MDSCs) 的综合性审查.
- 详细规范MDSC的发展和功能.
- 讨论MDSC作为预后/预测生物标志物,并探索治疗向策略.
主要方法:
- 对癌症中MDSCs现有研究的文献综述.
- 分析MDSC在免疫抑制,血管生成和转移中的作用.
- 检查针对MDSC的当前和新兴治疗方法.
主要成果:
- MDSC积累与癌症患者的预后不佳和治疗耐药性相关.
- MDSCs积极抑制各种免疫细胞,有助于免疫逃避.
- 向MDSC具有提高癌症治疗疗效和免疫监测的潜力.
结论:
- MDSCs是瘤免疫逃逸的关键调解者,并代表了一个重要的治疗点.
- 了解MDSC调节和功能对于开发有效的癌症治疗至关重要.
- 向MDSC可以通过克服免疫抑制和增强抗瘤免疫力来改善患者的治疗结果.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


